Who has invested in Nucleix?

RA Capital Management, BlackRock, Lilly Asia Ventures, OrbiMed, Sands Capital, LYFE Capital are named among the investors backing Nucleix.

Nucleix Funding: $143M Raised, Series C (2021)

Nucleix funding overview

Nucleix is based in San Diego, CA. Nucleix has raised $143M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in December 2021. The round record for Nucleix runs through 2021; nothing later has been disclosed. Investors on record include RA Capital Management, BlackRock, Lilly Asia Ventures, OrbiMed, Sands Capital, LYFE Capital and 4 others. 10 distinct backers are named across the disclosed rounds.

Nucleix at a glance

Total raised: $143M
Latest round: Series C
Latest round date: December 2021
Headquarters: San Diego, CA
Notable investors: RA Capital Management, BlackRock, Lilly Asia Ventures, OrbiMed, Sands Capital, LYFE Capital, Aurum Ventures, DSC Investment

Frequently asked about Nucleix funding

How much has Nucleix raised?: Nucleix has raised $143M in total disclosed funding across the rounds on record.
Who has invested in Nucleix?: RA Capital Management, BlackRock, Lilly Asia Ventures, OrbiMed, Sands Capital, LYFE Capital are named among the investors backing Nucleix.
What was the latest Nucleix funding round?: The most recent disclosed round is a Series C, announced in December 2021.
Where is Nucleix based?: Nucleix is based in San Diego, CA.
When did Nucleix last raise?: The last disclosed Nucleix round closed in December 2021 at Series C.

Nucleix totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in San Diego below to benchmark round size and investor mix.

Nucleix Funding: $143M Raised, Series C (2021)

Nucleix funding overview

Nucleix at a glance

Frequently asked about Nucleix funding

Companies related to Nucleix (35)

Browse related funding lists (8)